Anorectic adamantane derivatives and method of using the same

Details Anorectic adamantane derivatives and method of using the same Anorectic adamantane derivatives and method of using the same

1971-08-13

1978-07-11

Meyers, Albert T.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Recombinant or stably-transformed bacterium encoding one or...

424330, A01N 920, A01N 924

Patent

active

041001702

ABSTRACT:
Adamantane derivatives such as .beta.-(1-adamantyl)-.alpha.,.alpha.-dimethylethylamine hydrochloride, .beta.-(1-adamantyl)-.alpha.-methylethylamine hydrochloride, d-.beta.-(1-adamantyl)-.alpha.-methylethylamine hydrochloride, and 1-.beta.-(1-adamantyl)-.alpha.-methylethylamine hydrochloride have anorectic activity.
The hydrazine derivatives of the above compounds are antihypertensive agents, and monoamine oxidase inhibitors.

REFERENCES:
patent: 3270036 (1966-08-01), Bernstein et al.
patent: 3320249 (1967-05-01), Bernstein
patent: 3489802 (1970-01-01), Brake
patent: 3501511 (1970-03-01), Narayanan
patent: 3929888 (1975-12-01), Cashin et al.
patent: 4027035 (1977-05-01), Cashin et al.
Lunn et al., J. Chemical Soc. (1968) .COPYRGT. pp. 1657-1660.

Affiliated with

Also associated with

Rating

Anorectic adamantane derivatives and method of using the same does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anorectic adamantane derivatives and method of using the same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anorectic adamantane derivatives and method of using the same will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-261750